Keywords: pfizer, boosts, biotech, line, covx, buy, aim

Pfizer boosts biotech line with CovX buy

Article | 24 December 2007

Print This

With the aim of expanding its biotechnology pipeline, global pharmaceutical behemoth Pfizer has entered into an agreement to acquire CovX, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in